A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Bausch Health Companies Inc. (BHC) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2026-06-30, revenue was 10.9bn $, net income was -1.1bn $. Incorporated in the United States.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Bausch Health Companies Inc. (BHC) is a company in the Health care sector; its shares trade on NYSE.
The price of Bausch Health Companies Inc. (BHC) on November 20, 2026 is $8.23, −3.80% on the day. Over 52 weeks the stock traded between $4.33 and $9.04; the price now sits 83% of the way up that range. Over the past year the price changed by +36.12%. Market capitalisation is $3.16 billion, rank 54 among 379 stocks of the same industry with a known capitalisation.
Bausch Health Companies Inc. trades on NYSE under the ticker BHC. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BHC has traded between $4.33 and $9.04. As of 20 November 2026 the price stood 82.91% of the way from the 52-week low to the high.
Over one year BHC shares rose 26.13%; over six months they rose 54.06%. Volatility over 90 days is 78.12%. Dividends are not included: this is price change only, as of 20 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.3, below the sector median of 3.5. Calculated from reports for the period ending 30 June 2026.
Bausch Health Companies Inc. reported revenue of $10.9B and a net loss of $1.1B over the last four quarters. Net margin is −10.12%. Revenue changed by +10.09% year over year. Earnings per share are −$2.94. Market capitalisation is $3.2B.